Monographie - Gemcitabine hydrochloride

Zadnji put ažurirano :
03/05/2024

Gemcitabine hydrochloride

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Accogem	Meksiko
Antoril	Argentina
Axigem	Njemačka
Bendacitabin	Njemačka
Binoptos	Meksiko
Celzar	Peru
Dercin	Rumunjska
Dhacibine	Malezija
Emcitab	Kolumbija
Eriogem	Argentina, Ekvador
Fotinex	Argentina, Peru
Gebina	Argentina
Gebitan	Kolumbija
Gembio	Argentina, Čile, Ekvador
Gemcimira	Čile, Peru
Gemcit	Portugal
Gemcitabin	Njemačka
Gemcitac	Čile
Gemko	Turska
Gemsibin	Turska
Gemsol	Austrija
Gemtero	Čile, Peru
Gemzar	Australija, Austrija, Belgija, Brazil, Čile, Danska, Egipat, Ekvador, Finska, Francuska, Grčka, Hrvatska, Iran, Irska, Island, Italija, Južna Afrika, Kanada, Kolumbija, Luksemburg, Madžarska, Malezija, Maroko, Meksiko, Nizozemska, Njemačka, Norveška, Novi Zeland, Poljska, Portugal, Rumunjska, S A D, Slovenija, Španjolska, Švedska, Švicarska, Tajland, Tunis, Turska, Ujedinjeni Arapski Emirati, Velika Britanija, Venecuela
Gentabin	Kolumbija
Haxanit	Argentina, Peru
Lenfotabin	Meksiko

Bibliografija : Gemcitabine hydrochloride

	Vrsta	Publikacija
1422	Časopis	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Časopis	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Časopis	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Laboratorija	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Časopis	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Časopis	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Časopis	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Časopis	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Časopis	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Časopis	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Časopis	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Časopis	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Časopis	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Laboratorija	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Časopis	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Laboratorija	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Časopis	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Časopis	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Časopis	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales